TGFB1 and Hepatic fibrosis: Given the reported role of these two pathways in liver fibrosis and hepatic carcinoma, we anticipated that Oxy210 may inhibit liver pathology by its dual inhibitory effects on Hh and TGF‐β signalling pathways.